Caitlin Marie Dugdale, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sexually Transmitted Diseases | 2 | 2024 | 624 | 1.160 |
Why?
|
HIV Infections | 17 | 2024 | 16718 | 1.140 |
Why?
|
Trichomonas Infections | 1 | 2022 | 43 | 0.820 |
Why?
|
Infectious Disease Transmission, Vertical | 6 | 2023 | 1320 | 0.800 |
Why?
|
Anthozoa | 1 | 2021 | 62 | 0.790 |
Why?
|
Syphilis | 1 | 2024 | 227 | 0.780 |
Why?
|
Patient Isolation | 1 | 2020 | 100 | 0.710 |
Why?
|
Infant Care | 2 | 2020 | 183 | 0.670 |
Why?
|
Chlamydia Infections | 1 | 2022 | 365 | 0.640 |
Why?
|
Masks | 1 | 2020 | 197 | 0.640 |
Why?
|
Gonorrhea | 1 | 2022 | 335 | 0.620 |
Why?
|
Postnatal Care | 1 | 2019 | 236 | 0.610 |
Why?
|
Benzoxazines | 1 | 2019 | 301 | 0.600 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2019 | 215 | 0.590 |
Why?
|
Whipple Disease | 1 | 2016 | 19 | 0.580 |
Why?
|
Cost-Benefit Analysis | 6 | 2023 | 5391 | 0.500 |
Why?
|
Community Pharmacy Services | 1 | 2014 | 46 | 0.480 |
Why?
|
Coxiella burnetii | 1 | 2014 | 37 | 0.470 |
Why?
|
Q Fever | 1 | 2014 | 37 | 0.470 |
Why?
|
Fever of Unknown Origin | 1 | 2014 | 93 | 0.470 |
Why?
|
Endophthalmitis | 1 | 2016 | 262 | 0.460 |
Why?
|
Endocarditis | 1 | 2016 | 350 | 0.420 |
Why?
|
Pharmacists | 1 | 2014 | 248 | 0.410 |
Why?
|
Africa South of the Sahara | 3 | 2024 | 724 | 0.400 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2021 | 323 | 0.330 |
Why?
|
South Africa | 4 | 2022 | 1731 | 0.310 |
Why?
|
Anti-Retroviral Agents | 3 | 2023 | 1715 | 0.290 |
Why?
|
Cote d'Ivoire | 2 | 2023 | 56 | 0.280 |
Why?
|
HIV-1 | 1 | 2023 | 6939 | 0.250 |
Why?
|
Prevalence | 6 | 2024 | 15226 | 0.240 |
Why?
|
Pregnancy | 9 | 2024 | 29144 | 0.230 |
Why?
|
Mass Screening | 2 | 2021 | 5255 | 0.220 |
Why?
|
Communicable Diseases | 2 | 2021 | 880 | 0.220 |
Why?
|
Erythema | 1 | 2023 | 257 | 0.200 |
Why?
|
Physicians | 3 | 2022 | 4567 | 0.170 |
Why?
|
Infant | 7 | 2023 | 35136 | 0.170 |
Why?
|
Eye | 1 | 2023 | 729 | 0.170 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2019 | 1873 | 0.160 |
Why?
|
Alkynes | 1 | 2019 | 306 | 0.160 |
Why?
|
HIV Integrase Inhibitors | 1 | 2020 | 142 | 0.160 |
Why?
|
Cyclopropanes | 1 | 2019 | 416 | 0.150 |
Why?
|
Eye Diseases | 1 | 2023 | 669 | 0.150 |
Why?
|
Oxazines | 1 | 2019 | 298 | 0.150 |
Why?
|
Neural Tube Defects | 1 | 2019 | 256 | 0.140 |
Why?
|
Orchitis | 1 | 2016 | 35 | 0.140 |
Why?
|
Epididymitis | 1 | 2016 | 37 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 2 | 2021 | 783 | 0.140 |
Why?
|
Models, Economic | 1 | 2020 | 713 | 0.140 |
Why?
|
Humans | 30 | 2024 | 744343 | 0.140 |
Why?
|
Perinatal Care | 1 | 2018 | 227 | 0.140 |
Why?
|
HIV Antibodies | 1 | 2023 | 1322 | 0.130 |
Why?
|
Ceftriaxone | 1 | 2016 | 168 | 0.130 |
Why?
|
Medical Tourism | 1 | 2016 | 57 | 0.130 |
Why?
|
CD4 Lymphocyte Count | 1 | 2021 | 2559 | 0.130 |
Why?
|
Anti-HIV Agents | 2 | 2021 | 4256 | 0.130 |
Why?
|
Neurocysticercosis | 1 | 2015 | 62 | 0.130 |
Why?
|
Education, Pharmacy, Continuing | 1 | 2014 | 3 | 0.120 |
Why?
|
Animals, Domestic | 1 | 2014 | 56 | 0.120 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2021 | 2026 | 0.120 |
Why?
|
Infant, Newborn | 4 | 2023 | 25625 | 0.120 |
Why?
|
Pyridones | 1 | 2019 | 712 | 0.120 |
Why?
|
Disease Reservoirs | 1 | 2014 | 131 | 0.120 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1265 | 0.120 |
Why?
|
Myositis | 1 | 2016 | 251 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.110 |
Why?
|
Transaminases | 1 | 2014 | 199 | 0.110 |
Why?
|
Decision Support Systems, Clinical | 1 | 2022 | 1164 | 0.110 |
Why?
|
Child | 7 | 2023 | 77709 | 0.110 |
Why?
|
Zoonoses | 1 | 2014 | 185 | 0.110 |
Why?
|
Cerebral Ventricles | 1 | 2015 | 544 | 0.110 |
Why?
|
Female | 14 | 2024 | 380194 | 0.110 |
Why?
|
Hepatitis | 1 | 2014 | 227 | 0.110 |
Why?
|
Granuloma | 1 | 2014 | 319 | 0.100 |
Why?
|
Tachycardia | 1 | 2014 | 619 | 0.100 |
Why?
|
Inhalation Exposure | 1 | 2014 | 443 | 0.100 |
Why?
|
Nausea | 1 | 2014 | 673 | 0.100 |
Why?
|
Professional Role | 1 | 2014 | 306 | 0.100 |
Why?
|
Vomiting | 1 | 2014 | 636 | 0.100 |
Why?
|
Arthritis | 1 | 2016 | 659 | 0.100 |
Why?
|
Zimbabwe | 2 | 2022 | 129 | 0.100 |
Why?
|
Adult | 12 | 2023 | 214055 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1177 | 0.090 |
Why?
|
HIV | 3 | 2022 | 1604 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.090 |
Why?
|
Surgery, Plastic | 1 | 2016 | 624 | 0.090 |
Why?
|
Odds Ratio | 1 | 2021 | 9849 | 0.080 |
Why?
|
Piperazines | 1 | 2019 | 2488 | 0.080 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3589 | 0.070 |
Why?
|
Headache | 1 | 2014 | 1226 | 0.070 |
Why?
|
Brain Diseases | 1 | 2015 | 1563 | 0.070 |
Why?
|
Counseling | 1 | 2014 | 1523 | 0.070 |
Why?
|
Incidence | 2 | 2021 | 20947 | 0.070 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.070 |
Why?
|
Adolescent | 4 | 2022 | 85781 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2016 | 0.070 |
Why?
|
Male | 10 | 2023 | 350118 | 0.070 |
Why?
|
Software | 1 | 2019 | 4443 | 0.070 |
Why?
|
Models, Statistical | 1 | 2019 | 5102 | 0.060 |
Why?
|
Child, Preschool | 3 | 2022 | 41006 | 0.060 |
Why?
|
Early Diagnosis | 2 | 2021 | 1184 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2948 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8388 | 0.060 |
Why?
|
Isoindoles | 1 | 2022 | 41 | 0.050 |
Why?
|
Trifluridine | 1 | 2022 | 29 | 0.050 |
Why?
|
Monkeypox virus | 1 | 2022 | 48 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6756 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9856 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7181 | 0.050 |
Why?
|
Breast Feeding | 2 | 2020 | 1338 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
Health Policy | 2 | 2021 | 2661 | 0.040 |
Why?
|
Mozambique | 1 | 2018 | 54 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7474 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6234 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2023 | 77449 | 0.040 |
Why?
|
United States | 4 | 2022 | 69872 | 0.040 |
Why?
|
Community Health Centers | 1 | 2021 | 430 | 0.040 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2020 | 615 | 0.040 |
Why?
|
Animals | 2 | 2021 | 168757 | 0.030 |
Why?
|
Immunization | 1 | 2021 | 1256 | 0.030 |
Why?
|
Middle Aged | 3 | 2020 | 213383 | 0.030 |
Why?
|
Guatemala | 1 | 2015 | 142 | 0.030 |
Why?
|
Rhode Island | 1 | 2015 | 347 | 0.030 |
Why?
|
Drug Resistance, Viral | 1 | 2020 | 820 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1681 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1683 | 0.030 |
Why?
|
Postpartum Period | 1 | 2020 | 1086 | 0.030 |
Why?
|
Meningitis | 1 | 2015 | 216 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15295 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2022 | 1772 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5319 | 0.030 |
Why?
|
Life Expectancy | 1 | 2019 | 1184 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1425 | 0.020 |
Why?
|
Drainage | 1 | 2016 | 1142 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40561 | 0.020 |
Why?
|
Radiography | 1 | 2020 | 7023 | 0.020 |
Why?
|
Emigrants and Immigrants | 1 | 2015 | 522 | 0.020 |
Why?
|
Rural Population | 1 | 2018 | 2210 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10252 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4468 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12951 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6196 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9583 | 0.010 |
Why?
|
Developing Countries | 1 | 2016 | 2815 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15540 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 5987 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9959 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12959 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 72290 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63114 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35421 | 0.000 |
Why?
|
Aged | 1 | 2020 | 163280 | 0.000 |
Why?
|